Overview

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Status:
Completed

Trial end date:
2018-06-04

Target enrollment:

Participant gender:

Summary

The primary purpose of this protocol is to evaluate the safety of Apixaban in prophylaxis of Venous Thromboembolism (VTE) in Indian patients undergoing elective total knee or hip replacement

Phase:

Phase 4

Details

Lead Sponsor:

Bristol-Myers Squibb

Collaborator:

Pfizer

Treatments:

Apixaban